Source Post
Grading the Dividend Kings: Who Deserves an A (Who Fails the Test) 👑
Sep 8, 2025
The creator grades Dividend Kings, expressing a controversial opinion that Abbott Laboratories (ABT) is superior to S&P Global (SPGI) based on dividend profile. The creator also highlights Target (TGT) as a potential buying opportunity due to its current valuation and attractive dividend yield.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.